COMPLEX CORRECTION OF VASCULAR HEMOSTASIS IN PATIENTS WITH ARTERIAL HYPERTENSION, METABOLIC SYNDROME, AND RECENT OCULAR VESSEL OCCLUSION

COMPLEX CORRECTION OF VASCULAR HEMOSTASIS IN PATIENTS WITH ARTERIAL HYPERTENSION, METABOLIC SYNDROME, AND RECENT OCULAR VESSEL OCCLUSION

The study was aimed at the evaluation of complex therapy (diltiazem, pioglitazone, and non-pharmaceutical measures) in the correction of anticoagulant, fibrinolytic, and anti-aggregant vascular wall activity among patients with arterial hypertension, metabolic syndrome, and recent ocular vessel occl...

Full description

Bibliographic Details
Main Authors: I. N. Medvedev, O. A. Danilenko
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2010-08-01
Series:Российский кардиологический журнал
Subjects:
vascular wall
arterial hypertension
metabolic syndrome
recent ocular vessel thrombosis
complex correction
Online Access:https://russjcardiol.elpub.ru/jour/article/view/1462
id doaj-0e00871fdaa24eeab96fcf3b0889ac78
record_format Article
spelling doaj-0e00871fdaa24eeab96fcf3b0889ac782021-07-28T14:02:14Zrus«FIRMA «SILICEA» LLC Российский кардиологический журнал1560-40712618-76202010-08-010415191249COMPLEX CORRECTION OF VASCULAR HEMOSTASIS IN PATIENTS WITH ARTERIAL HYPERTENSION, METABOLIC SYNDROME, AND RECENT OCULAR VESSEL OCCLUSIONI. N. Medvedev0O. A. Danilenko1Курский институт социального образования – филиал Российского государственного социального университета, КурскКурский институт социального образования – филиал Российского государственного социального университета, КурскThe study was aimed at the evaluation of complex therapy (diltiazem, pioglitazone, and non-pharmaceutical measures) in the correction of anticoagulant, fibrinolytic, and anti-aggregant vascular wall activity among patients with arterial hypertension, metabolic syndrome, and recent ocular vessel occlusion. It was demonstrated that after 4 months of the above-mentioned complex therapy, the anticoagulant, fibrinolytic, and anti-aggregant vascular wall activity was improved, but not normalised. At the same time, the investigated parameters significantly deteriorated if the non-pharmaceutical therapy compliance was low.https://russjcardiol.elpub.ru/jour/article/view/1462vascular wallarterial hypertensionmetabolic syndromerecent ocular vessel thrombosiscomplex correction
collection DOAJ
language Russian
format Article
sources DOAJ
author I. N. Medvedev
O. A. Danilenko
spellingShingle I. N. Medvedev
O. A. Danilenko
COMPLEX CORRECTION OF VASCULAR HEMOSTASIS IN PATIENTS WITH ARTERIAL HYPERTENSION, METABOLIC SYNDROME, AND RECENT OCULAR VESSEL OCCLUSION
Российский кардиологический журнал
vascular wall
arterial hypertension
metabolic syndrome
recent ocular vessel thrombosis
complex correction
author_facet I. N. Medvedev
O. A. Danilenko
author_sort I. N. Medvedev
title COMPLEX CORRECTION OF VASCULAR HEMOSTASIS IN PATIENTS WITH ARTERIAL HYPERTENSION, METABOLIC SYNDROME, AND RECENT OCULAR VESSEL OCCLUSION
title_short COMPLEX CORRECTION OF VASCULAR HEMOSTASIS IN PATIENTS WITH ARTERIAL HYPERTENSION, METABOLIC SYNDROME, AND RECENT OCULAR VESSEL OCCLUSION
title_full COMPLEX CORRECTION OF VASCULAR HEMOSTASIS IN PATIENTS WITH ARTERIAL HYPERTENSION, METABOLIC SYNDROME, AND RECENT OCULAR VESSEL OCCLUSION
title_fullStr COMPLEX CORRECTION OF VASCULAR HEMOSTASIS IN PATIENTS WITH ARTERIAL HYPERTENSION, METABOLIC SYNDROME, AND RECENT OCULAR VESSEL OCCLUSION
title_full_unstemmed COMPLEX CORRECTION OF VASCULAR HEMOSTASIS IN PATIENTS WITH ARTERIAL HYPERTENSION, METABOLIC SYNDROME, AND RECENT OCULAR VESSEL OCCLUSION
title_sort complex correction of vascular hemostasis in patients with arterial hypertension, metabolic syndrome, and recent ocular vessel occlusion
publisher «FIRMA «SILICEA» LLC 
series Российский кардиологический журнал
issn 1560-4071
2618-7620
publishDate 2010-08-01
description The study was aimed at the evaluation of complex therapy (diltiazem, pioglitazone, and non-pharmaceutical measures) in the correction of anticoagulant, fibrinolytic, and anti-aggregant vascular wall activity among patients with arterial hypertension, metabolic syndrome, and recent ocular vessel occlusion. It was demonstrated that after 4 months of the above-mentioned complex therapy, the anticoagulant, fibrinolytic, and anti-aggregant vascular wall activity was improved, but not normalised. At the same time, the investigated parameters significantly deteriorated if the non-pharmaceutical therapy compliance was low.
topic vascular wall
arterial hypertension
metabolic syndrome
recent ocular vessel thrombosis
complex correction
url https://russjcardiol.elpub.ru/jour/article/view/1462
work_keys_str_mv AT inmedvedev complexcorrectionofvascularhemostasisinpatientswitharterialhypertensionmetabolicsyndromeandrecentocularvesselocclusion
AT oadanilenko complexcorrectionofvascularhemostasisinpatientswitharterialhypertensionmetabolicsyndromeandrecentocularvesselocclusion
_version_ 1721269510583877632

Similar Items